GPX4 and neoplasm: By down-regulating glutathione peroxidase 4 (GPX4), the platform synergizes with IFN-γ-induced ferroptotic signaling to intensify tumor-cell lethality, establishing a positive-feedback loop between immune activation and regulated cell death that amplifies antitumor efficacy.